Grant Bogle joined US Oncology, now McKesson Specialty Health, in June 2007 as senior vice president, regional operations, Northeast region. In the summer of 2009, he was appointed to the executive committee of US Oncology, and later assumed responsibility overseeing research, marketing, communications and bio-pharmaceutical sales. Following the merger between McKesson Specialty Care Solutions and US Oncology. Bogle assumed responsibility for the majority of MSH’s pharmaceutical and biotech-facing businesses including US Oncology Research (USOR), Reimbursement, Access and Safety Services (RA&SS) and Informatics.Previously, Bogle was senior vice president of sales and marketing for Millennium Pharmaceuticals where he was responsible for the oncology product, VELCADE. Prior to joining Millennium, he held senior sales and marketing roles with Roche Pharmaceuticals, Knoll Pharmaceuticals, DuPont, and American Critical Care (a division of American Hospital Supply Corp). He holds an MBA from Columbia University and an undergraduate degree in economics from Dartmouth College.